If your business has been investing in new systems, software, processes, or products over the last few years, the R&D tax credit just got a lot more valuable.
When President Trump signed the One Big Beautiful Bill Act on July 4, 2025, it didn’t just fix the painful “five-year amortization” rules on research expenses. It also opened a special, roughly one-year window for many small and mid-sized businesses to go back three years (2022–2024) and unlock a pile of cash tied up in R&D deductions and the R&D tax credit.
In plain English:
If you’ve been doing qualifying R&D work and filing returns since 2022, you may be able to amend those returns, fix how your research costs were treated, and stack three years of R&D tax credit savings into a single shot — but only if you act before early July 2026 (current guidance points to July 6, 2026, the business day after the July 4th holiday).
Let’s walk through what changed, who qualifies, and why ignoring this window could easily be a six-figure mistake.
Quick Refresher: What Is the R&D Tax Credit?
The R&D tax credit is a federal incentive designed to reward businesses that develop or improve products, processes, techniques, formulas, software, or systems.
You don’t need white lab coats or patents. In fact, for many small and mid-sized companies, qualifying work looks more like:
Improving an internal workflow or production process
Developing or customizing software
Refining a treatment method or clinical protocol
Testing new materials, formulas, or product variations
Experimenting with different configurations to solve technical problems
Under the tax code, qualifying research expenses (QREs) have to pass a basic four-part test:
Permitted purpose – You’re trying to improve a product, process, software, technique, formula, or invention.
Technological in nature – The work relies on principles of physical science, biological science, computer science, or engineering.
Elimination of uncertainty – At the start, you didn’t know if you could achieve the desired result or how to get there.
Process of experimentation – You evaluated alternatives through modeling, simulation, trials, or iterative testing.
If your team has been designing, testing, prototyping, or iterating in any systematic way, there’s a good chance you have qualifying R&D activity.
The R&D tax credit then lets you convert a portion of those costs into:
A direct offset to income tax, or
For certain small startups, an offset to payroll tax
That means dollar-for-dollar reduction of your tax bill, not just a deduction.
What the New Law Changed in 2025
Back in 2022, an earlier law forced domestic R&D costs to be capitalized and amortized over five years under Internal Revenue Code Section 174. That slowed deductions, hurt cash flow, and created a mess for tax planning, especially for smaller, growing companies.
The One Big Beautiful Bill Act (OBBBA) reversed that for domestic research:
It restores immediate expensing of qualified domestic research and experimental (R&E) costs for tax years beginning after December 31, 2024.
It gives special relief for past years, letting many small businesses retroactively fix how 2022–2024 research costs were treated and amend returns.
It coordinates with the R&D tax credit rules and allows late or revised elections around how deductions and credits interact (for example, the reduced credit election under Section 280C).
For qualifying small businesses — generally those with average annual gross receipts under about $31 million — the law now allows you to: Adams Brown+1
Amend your 2022, 2023, and 2024 tax returns to fully deduct domestic R&D expenses that were previously being amortized.
Align those deductions with your R&D tax credit to maximize overall savings.
Make late elections or revocations related to how your credit is computed — something that historically could only be done on the original return. CohnReznick+1
The catch:
These retroactive elections must be made by early July 2026 (currently July 6, 2026) or before your normal statute of limitations runs out, whichever comes first. Adams Brown+1
After that, the window closes. You’ll still be able to claim the R&D tax credit going forward, but the chance to compress three open years of benefit into one concentrated refund opportunity is gone.
How the New Window Works With the R&D Tax Credit
Even before OBBBA, you could sometimes amend returns for open years and claim missed R&D tax credits. The new law supercharges that by fixing the deduction side of the equation and giving special permission to:
Revisit how R&D expenses were treated in 2022–2024
Line that up with your R&D tax credit claims
Restructure elections (like the reduced credit) that affect the size of your credit and deduction package
For many businesses, that means:
You deduct more, sooner (thanks to the Section 174 fix), AND
You claim the R&D tax credit on those same qualifying research expenses, subject to the usual coordination rules
The result is often significant refunds across three years that can all hit roughly the same time — if you plan and file correctly during this special window.
Who Should Be Paying Attention?
If you check any of these boxes, you should be looking hard at the R&D tax credit right now:
1. You’re a U.S. business with technical or process-driven work
Industries that frequently qualify include:
Manufacturing & fabrication
Software and SaaS
Medical practices and dental labs
Architecture, engineering, and design firms
Biotech, pharma, and medical devices
Food and beverage production
Agriculture and precision farming
Industrial services and automation
If your people are building, testing, or improving anything in a systematic way, the R&D tax credit is likely on the table.
2. You had domestic R&D expenses from 2022–2024
If you incurred domestic research or experimentation costs in 2022, 2023, or 2024 and had to start amortizing them over five years, OBBBA may allow you to:
Stop that amortization,
Deduct remaining amounts immediately, or
Even retroactively expense those years through amended returns, depending on your situation.
3. Your average annual gross receipts are under ~$31 million
The most generous retroactive options (three open years, simplified retroactive application) are aimed at qualified small businesses, typically defined as having average annual gross receipts of $31 million or less over a testing period.
Larger companies still benefit from the Section 174 fix and R&D tax credit, but the rules and elections get more complex.
4. Your CPA hasn’t brought this up yet
This is important to say out loud:
Most general CPAs do not specialize in the R&D tax credit or Section 174.
The new guidance around OBBBA, Rev. Proc. 2025-28, Form 6765 changes, and retroactive elections is dense, technical, and moving fast.
If no one has sat down with you to model:
Your 2022–2024 R&D spend
The potential R&D tax credit for those years
The impact of retroactive expensing vs. continuing amortization
…then you’re flying blind during a very short opportunity window.
What Actually Counts as R&D for the Credit?
Here’s where most business owners are pleasantly surprised.
You do not need to be inventing a new drug or building a rocket. The R&D tax credit often covers work you’d describe as “just improving how we do things.”
Example activities that often qualify:
Implementing or testing new software or custom integrations
Developing internal tools or dashboards to run your operations
Designing, prototyping, or testing new product variations
Improving manufacturing or treatment methods to reduce defects, time, or cost
Experimenting with new materials, formulas, or packaging
Creating more efficient sterilization, workflow, or patient-flow systems in a medical or dental practice
Building or refining automation in a production line
If your team is:
Documenting requirements
Building prototypes or beta versions
Running tests, pilots, or A/B comparisons
Iterating based on results
…that’s the heart of what the IRS considers a “process of experimentation”, which is central to qualifying for the R&D tax credit.
Why You Should Move Before July 2026
Let’s be blunt: the IRS is not going to call you and say, “Hey, you can get three years of R&D tax credit refunds if you hurry.”
There are some very real reasons to move now, not in 2026:
1. Three years of benefit in one window
The combination of:
Retroactive expensing for 2022–2024
Retroactive and late elections around the R&D credit
Amended returns for those same years
…creates a one-time chance to pull three years of tax savings forward.
For some companies, that’s easily six figures in cash, sometimes more.
2. Documentation and reporting are tightening
The IRS has already started tightening requirements around how you document and report R&D activity. For example, Form 6765 (the R&D credit form) is being updated with new Section G requirements, which become mandatory for most taxpayers starting with the 2026 filing season.
That doesn’t mean you should fear the credit; it just means:
Sloppy DIY claims are a bad idea.
Doing this with experts who understand both technical documentation and tax rules is becoming more important.
3. Cash is king in an uncertain economy
The big companies have already noticed. Analysts have pointed out that tech firms with heavy R&D spending stand to see measurable boosts in free cash flow thanks to the new law’s expensing and retroactive relief. Business Insider
If giants like Microsoft and Adobe are using the new rules to improve their cash and earnings, smaller businesses should be asking a very simple question:
“Why wouldn’t we do the same thing while the window is open?”
4. The window closes — and it’s not likely to be extended
Tax “transition relief” like this tends to be one-time. Once the July 2026 deadline passes and the statutes of limitation close on earlier years, it becomes much harder — or impossible — to go back and reclaim those dollars.
At that point, the question shifts from:
“Can we still get this money?”
to
“Why did we leave it on the table?”
Common Misconceptions About the R&D Tax Credit
A few beliefs keep business owners from claiming what they’re owed:
“We don’t do R&D.”
You probably do — you just don’t call it that.
If you are:
Improving efficiency
Reducing errors or rework
Customizing systems
Building better internal tools
…you’re likely doing R&D work in the eyes of the tax code.
“If we qualified, our CPA would have told us.”
Maybe. But:
Most CPAs focus on compliance, not specialized credits.
The R&D tax credit and Section 174 rules are niche, technical areas.
OBBBA and its guidance are brand-new, and many firms are still digesting the changes.
This isn’t an insult to your CPA. It’s just reality: R&D is an area where specialization matters.
“We’re too small.”
The new rules specifically target small and mid-sized businesses with under ~$31 million in annual gross receipts for the most generous retroactive relief. Adams Brown+1
In other words, you are exactly the type of company Congress had in mind.
“We’re worried about triggering an audit.”
The R&D tax credit has been around for decades. The IRS expects legitimate claims. The real risk isn’t using the credit — it’s using it sloppily:
No contemporaneous documentation
Vague or inflated project descriptions
Poor coordination between technical and tax teams
Handled correctly, with proper documentation and a clear methodology, R&D claims are a normal part of the tax system — not a red flag.
A Simple Action Plan
If you think you might have qualifying R&D activity — or you’re not sure — here’s a straightforward path:
Step 1: Collect the basics
Pull together:
Tax returns for 2022, 2023, and 2024
Any schedules showing R&D, engineering, or software costs
High-level descriptions of your major projects or process improvements in those years
You don’t need every detail yet — just enough to have an intelligent conversation.
Step 2: Get a proper R&D review
Work with a firm that:
Specializes in the R&D tax credit (not just generic tax prep)
Understands both Section 41 (credit) and Section 174 (deductions) under the new law
Can coordinate with your existing CPA rather than replacing them
The goal is to:
Identify qualifying activities
Quantify potential R&D tax credits for 2022–2024
Model the impact of retroactive expensing vs. continued amortization
Map deadlines for amended returns and elections, including the July 2026 cutoff
Step 3: Decide your strategy — and execute before the deadline
Once you have the numbers, you can decide:
Which years to amend
How to structure elections (such as reduced-credit vs full-credit with add-back)
How to coordinate with state R&D credits, where available
How to document projects going forward so you’re ready for 2025 and beyond
The key is simple: Don’t let the calendar make the decision for you.
Final Thoughts
The R&D tax credit has always been one of the most powerful incentives in the U.S. tax code. With the One Big Beautiful Bill’s changes, it’s now paired with a rare chance to:
Fix past years (2022–2024)
Align your deductions and credits
Potentially create a multi-year cash infusion — if you move before the July 2026 deadline. Source Advisors+3UHY+3Adams Brown+3
If you’ve been quietly investing in innovation, process improvement, or custom software, this is the moment to stop guessing and get a real analysis.
The IRS wrote the rules. Congress opened this window.
Your job is to decide whether you’re going to use it — or fund Washington a little more than you legally have to.